from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0538/-

LFCtreatmentdescriptionclass of inhibitor

-0.719

Amikacinug/mL Amikacintranslation

-0.162

Cap5-10ug/mL Capreomycintranslation

1.519

Rox10-50 ug/mL Roxithromycintranslation

-0.445

SM2-5 ug/mL Streptomycintranslation

-0.966

Tet5-10 ug/mL Tetracyclinetranslation

-0.675

Rif0.2-5ug/mL Rifampicintranscription

-0.930

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.013

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.026

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.417

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.055

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.041

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.148

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.693

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.292

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.970

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.752

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

2.163

NaN30.2-2 mM Sodium aziderespiration

-1.255

Nigericin50 uM Nigericinrespiration

-0.317

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.197

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.236

menadione6-10 ug/mL Menadionerespiration

0.663

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.007

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.003

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.688

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.575

NRP_1Non-replicating persistence stage 1dosRassociated

-0.167

Amp0.2mg/mL AmpicillincellWall

-0.428

Cephalexin20-100 ug/mL CephalexincellWall

0.692

Cerulenin0.32-5 ug/mL CerulenincellWall

0.246

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.071

EMB10-20 ug/mL EthambutolcellWall

0.010

Eta12-40 ug/mL EthionamidecellWall

-0.278

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.569

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.604

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.622

BZA0.12 mg/mL BenzamidearomaticAmides

0.551

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.332

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.026

H2O24 mM hydrogen peroxideDNAdamaging

-0.484

Levo10 ug/mL LevofloxacinDNAdamaging

0.346

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.367

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.234

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.724

UVUV-irradiationDNAdamaging

-1.856

ARP41-4 ug/mL Antitubercular compound ARP4?

0.031

Antimycin12.5-50 ug/mL Antimycin A?

-1.772

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.075

PA_110-50 ug/mL Antitubercular compound PA-1?

0.403

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.544

PA8240.2-2 ug/mL PA-824?

0.916

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.404

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.891

Verapamil50 uM Verapamil?

-2.215

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.989

methoxatin10-20 ug/mL Methoxatin?